MedAdvisor Receives Nonbinding Letter of Intent from Multinational Software Firm, Shares Soar 30%

MT Newswires Live

2025/05/07

MedAdvisor (ASX:MDR) received a nonbinding letter of intent from a multinational software business with operations in Australia to acquire MedAdvisor's Australia and New Zealand business division in cash, according to a Wednesday Australian bourse filing.

The firm's directors believe the bid to be a materially higher value than what is implied in the current MedAdvisor share price, and it has executed the letter of intent in the best interest of shareholders.

The letter of intent includes customary conditions such as a period of exclusivity to conduct due diligence. The time frame to execute a binding sale and purchase agreement is expected to be around five to seven weeks.

Adelaide Equity Partners and HWL Ebsworth are advising on the potential transaction and are assisting with an ongoing strategic review process.

Its shares soared 30% in recent trading on Wednesday.

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/news/2533623344"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2533623344\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2533623344?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-05-07 13:44","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2533623344","market":"sh","top_or_hot":-1,"title":"MedAdvisor Receives Nonbinding Letter of Intent from Multinational Software Firm, Shares Soar 30%","media":"MT Newswires Live","content":"<html><body><p> MedAdvisor (ASX:MDR) received a nonbinding letter of intent from a multinational software business with operations in Australia to acquire MedAdvisor's Australia and New Zealand business division in cash, according to a Wednesday Australian bourse filing.</p><p>The firm's directors believe the bid to be a materially higher value than what is implied in the current MedAdvisor share price, and it has executed the letter of intent in the best interest of shareholders.</p><p>The letter of intent includes customary conditions such as a period of exclusivity to conduct due diligence. The time frame to execute a binding sale and purchase agreement is expected to be around five to seven weeks.</p><p>Adelaide Equity Partners and HWL Ebsworth are advising on the potential transaction and are assisting with an ongoing strategic review process.</p><p>Its shares soared 30% in recent trading on Wednesday.</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>MedAdvisor Receives Nonbinding Letter of Intent from Multinational Software Firm, Shares Soar 30%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMedAdvisor Receives Nonbinding Letter of Intent from Multinational Software Firm, Shares Soar 30%\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1092851196\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">MT Newswires Live </p>\n<p class=\"h-time smaller\">2025-05-07 13:44</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<html><body><p> MedAdvisor (ASX:MDR) received a nonbinding letter of intent from a multinational software business with operations in Australia to acquire MedAdvisor's Australia and New Zealand business division in cash, according to a Wednesday Australian bourse filing.</p><p>The firm's directors believe the bid to be a materially higher value than what is implied in the current MedAdvisor share price, and it has executed the letter of intent in the best interest of shareholders.</p><p>The letter of intent includes customary conditions such as a period of exclusivity to conduct due diligence. The time frame to execute a binding sale and purchase agreement is expected to be around five to seven weeks.</p><p>Adelaide Equity Partners and HWL Ebsworth are advising on the potential transaction and are assisting with an ongoing strategic review process.</p><p>Its shares soared 30% in recent trading on Wednesday.</p></body></html>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"XAO.AU","symbol_name":"標普/澳交所 普通股指數","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2533623344","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2533623344","pubTimestamp":1746596660,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"MedAdvisor  received a nonbinding letter of intent from a multinational software business with operations in Australia to acquire MedAdvisor's Australia and New Zealand business division in cash, according to a Wednesday Australian bourse filing.The firm's directors believe the bid to be a materially higher value than what is implied in the current MedAdvisor share price, and it has executed the letter of intent in the best interest of shareholders.The letter of intent includes customary conditions such as a period of exclusivity to conduct due diligence. The time frame to execute a binding sale and purchase agreement is expected to be around five to seven weeks.Adelaide Equity Partners and HWL Ebsworth are advising on the potential transaction and are assisting with an ongoing strategic review process.Its shares soared 30% in recent trading on Wednesday.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"XAO.AU":"标普/澳交所 普通股指数","XKO.AU":"标普/澳交所 300指数","BK7094":"医疗保健技术","XJO.AU":"标普/澳交所 200指数"},"translate_title":"MedAdvisor收到跨国软件公司不具约束力的意向书，股价飙升30%","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"MDR.AU":0.9,"XAO.AU":0.9,"XKO.AU":0.9,"XJO.AU":0.9},"content_text":"MedAdvisor (ASX:MDR) received a nonbinding letter of intent from a multinational software business with operations in Australia to acquire MedAdvisor's Australia and New Zealand business division in cash, according to a Wednesday Australian bourse filing.The firm's directors believe the bid to be a materially higher value than what is implied in the current MedAdvisor share price, and it has executed the letter of intent in the best interest of shareholders.The letter of intent includes customary conditions such as a period of exclusivity to conduct due diligence. The time frame to execute a binding sale and purchase agreement is expected to be around five to seven weeks.Adelaide Equity Partners and HWL Ebsworth are advising on the potential transaction and are assisting with an ongoing strategic review process.Its shares soared 30% in recent trading on Wednesday.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"2","news_tag":"corporation","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}